Mary Ruth Cromwell

age ~82

from Kansas City, KS

Get Report

Also known as:

Connected to:

Mary Cromwell Phones & Addresses

Antibody Formulation
view source
US Patent:

20200392220, Dec 17, 2020
Filed:

Feb 21, 2020
Appl. No.:

16/798211
Inventors:

- South San Francisco CA, US
Timothy J. KAMERZELL - Overland Park KS, US
Megan LI - San Francisco CA, US
Mary CROMWELL - Redwood City CA, US
Hong LIU - Foster City CA, US
Assignee:

Genentech, Inc. - South San Francisco CA
International Classification:

C07K 16/22
A61K 9/00
A61K 39/395
A61K 47/18
A61K 47/26
A61K 47/22
A61J 1/20
A61J 1/14
Abstract:

The invention provides a stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, optionally, not subjected to prior lyophilization, a buffer maintaining the pH in the range from about 4.0 to about 6.0, and an optional surfactant, methods for making such a formulation, and methods of using such a formulation.

Antibody Formulation
view source
US Patent:

20180171004, Jun 21, 2018
Filed:

Jul 24, 2017
Appl. No.:

15/658306
Inventors:

- South San Francisco CA, US
Timothy J. KAMERZELL - Overland Park KS, US
Megan LI - San Francisco CA, US
Mary CROMWELL - Redwood City CA, US
Hong LIU - Foster City CA, US
International Classification:

C07K 16/22
A61K 47/18
A61J 1/14
A61K 9/00
A61K 47/26
A61K 47/22
A61J 1/20
A61K 39/395
A61K 39/00
Abstract:

The invention provides a stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, optionally, not subjected to prior lyophilization, a buffer maintaining the pH in the range from about 4.0 to about 6.0, and an optional surfactant, methods for making such a formulation, and methods of using such a formulation.

Antibody Formulation
view source
US Patent:

20160251422, Sep 1, 2016
Filed:

Nov 25, 2015
Appl. No.:

14/952551
Inventors:

- South San Francisco CA, US
Timothy J. KAMERZELL - Overland Park KS, US
Megan LI - San Francisco CA, US
Mary CROMWELL - Redwood City CA, US
Hong LIU - Foster City CA, US
International Classification:

C07K 16/22
A61J 1/20
A61J 1/14
Abstract:

The invention provides a stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, optionally, not subjected to prior lyophilization, a buffer maintaining the pH in the range from about 4.0 to about 6.0, and an optional surfactant, methods for making such a formulation, and methods of using such a formulation.

Antibody Formulation
view source
US Patent:

20140099301, Apr 10, 2014
Filed:

Oct 4, 2013
Appl. No.:

14/046909
Inventors:

- South San Francisco CA, US
Timothy J. Kamerzell - Overland Park KS, US
Megan Li - San Francisco CA, US
Mary Cromwell - Redwood City CA, US
Hong Liu - Foster City CA, US
Assignee:

Genentech, Inc. - South San Francisco CA
International Classification:

A61K 39/395
A61K 47/22
A61K 47/18
US Classification:

4241331, 4241301, 4241451, 4241581, 206525
Abstract:

The invention provides a stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, optionally, not subjected to prior lyophilization, a buffer maintaining the pH in the range from about 4.0 to about 6.0, and an optional surfactant, methods for making such a formulation, and methods of using such a formulation.